Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;20(7):673-686.
doi: 10.1080/14737175.2020.1775585. Epub 2020 Jun 27.

The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders

Urdhva Raval  1 , Joyce M Harary  1 , Emma Zeng  1 , Giulio M Pasinetti  1   2
Affiliations
Review

The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders

Urdhva Raval et al. Expert Rev Neurother. 2020 Jul.

Abstract

Introduction: Age related neurodegenerative disorders affect millions of people around the world. The role of the gut microbiome (GM) in neurodegenerative disorders has been elucidated over the past few years. Dysbiosis of the gut microbiome ultimately results in neurodegeneration. However, the gut microbiome can be modulated to promote neuro-resilience.

Areas covered: This review is focused on demonstrating the role of the gut microbiome in host physiology in Parkinson's disease (PD) and other neurodegenerative disorders. We will discuss how the microbiome will impact neurodegeneration in PD, Alzheimer's Disease (AD), Multiple sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), and finally discuss how the gut microbiome can be influenced through diet and lifestyle.

Expert opinion: Currently, much of the focus has been to study the mechanisms by which the microbiome induces neuroinflammation and neurodegeneration in PD, AD, MS, ALS. In particular, the role of certain dietary flavonoids in regulation of gut microbiome to promote neuro-resilience. Polyphenol prebiotics delivered in combination with probiotics (synbiotics) present an exciting new avenue to harness the microbiome to attenuate immune inflammatory responses which ultimately may influence brain cascades associated with promotion of neurodegeneration across the lifespan.

Keywords: Gut microbiome; alzheimer’s disease; gut dysbiosis; neuro-resilience; neurodegenerative disorders; parkinson’s disease; polyphenols; probiotics; synbiotics.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed.

Figures

Figure 1.
Figure 1.
Demonstrates the NLRP3 inflammasome activation by gut microbiome dysbiosis and subsequent pathway resulting in pro-inflammatory cytokine mediated neurodegeneration.
Figure 2.
Figure 2.
Represents factors alter the gut microbiome. Factors, such as western diet and environmental toxins that cause gut microbiome dysbiosis. In contrast, consumption of polyphenols, probiotics, and synbiotics as well as an active lifestyle result in a healthy gut.
Figure 3.
Figure 3.
Demonstrates how a dietary polyphenol metabolite, 3-hydroxybenzoic acid (3-HBA) inhibits alpha synuclein and amyloid-beta accumulation.
See this image and copyright information in PMC

References

    1. Guarner F, Malagelada J-R. Gut flora in health and disease. The Lancet. 2003;361:512–519. - PubMed
    1. Turnbaugh PJ, Ley RE, Hamady M, et al. The Human Microbiome Project . Nature. 2007;449:804–810. - PMC - PubMed
    1. Sender R, Fuchs S, Milo R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016;14:e1002533. - PMC - PubMed
    1. Rajilić-Stojanović M Function of the microbiota. Best Practice & Research Clinical Gastroenterology. 2013;27:5–16. - PubMed
    1. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009;15:1546–1558. - PubMed

Publication types

MeSH terms